Thermodynamic stability and anticancer activity of 2,3-unsaturated and 2,3-dideoxy O3-betulin glycosides
Grzegorz Detlaff1, Aleksandra Hać2, Daria Grzywacz1
1Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, Gdańsk, 80-308, Poland.
Abstract:
Derivatization of natural compounds with established cytotoxic activity is a common strategy in development of new anticancer agents. This approach is exemplified by betulin, a triterpenoid from birch bark that exhibits pronounced antiproliferative effects against various cancer cell lines. We used the Ferrier rearrangement to synthesize 2,3-unsaturated O3-betulin glycosides, which were converted into 2,3-dideoxy analogs via regioselective hydrogenation. The conformations of the 2,3-unsaturated O3-betulin glycosides are analyzed in relation to the stereoselectivity of the Ferrier rearrangement. Cytotoxicity studies of the synthesized O3-betulin glycosides were performed against breast cancer cells (MCF7 cell line), prostate cancer cells (PC3 cell line), and human keratinocytes (HaCaT cell line). These reveal that glycosylation of betulin with 2,3-unsaturated and 2,3-dideoxy sugars derived from D-xylose, L-arabinose, and L-fucose clearly enhances its activity against MCF7 cells. This improvement is accompanied by high selectivity of the active compounds. Structure-activity relationship analysis leads to the conclusion that enhanced activity is associated with the absence of a terminal hydroxymethyl group. Microscopic images of MCF7 cells treated with the synthesized glycosides illustrate vacuolization, membrane blebbing, and apoptotic disintegration. Presented studies show the anticancer potential of some of the O3-betulin glycosides and provide insight into the stereoselectivity of the Ferrier rearrangement.
Related Concept Videos
Stability of Conjugated Dienes
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

